Sugimoto M, Yamanouchi K
Department of Preventive Medicine, Nagasaki University, Japan.
Vaccine. 1994 Jun;12(8):675-81. doi: 10.1016/0264-410x(94)90215-1.
This article reviews studies concerning the characteristics of a vaccinia virus strain, LC16m0, and its recombinant virus vaccines. The LC16m0 strain is one of several temperature-sensitive and further attenuated variants derived from the Lister (Elstree) strain of vaccinia virus, which has a proven safety record in human populations. Several types of recombinant vaccinia viruses expressing a foreign antigen gene from a pathogenic virus have been constructed using the LC16m0 strain as a vector, and their immunological and virological characteristics have been investigated extensively. These studies indicate that the LC16m0 strain has potential as a vector in a live recombinant vaccine. The advantages, disadvantages and future prospects of vector are discussed.
本文综述了有关痘苗病毒株LC16m0及其重组病毒疫苗特性的研究。LC16m0株是源自痘苗病毒利斯特(埃尔斯特里)株的几种温度敏感且进一步减毒的变体之一,该毒株在人群中具有经证实的安全记录。已使用LC16m0株作为载体构建了几种表达来自致病病毒的外源抗原基因的重组痘苗病毒,并对其免疫学和病毒学特性进行了广泛研究。这些研究表明,LC16m0株作为活重组疫苗的载体具有潜力。文中讨论了该载体的优缺点及未来前景。